Flok Health is a technology company.
Flok Health has raised $4.0M across 1 funding round.
Flok Health has raised $4.0M in total across 1 funding round.
Flok Health has raised $4.0M in total across 1 funding round.
Flok Health's investors include Aidan Corbett.
Flok Health is a UK-based technology company developing the world's first AI-powered physiotherapy clinic, focusing on musculoskeletal (MSK) conditions like back pain. It builds a digital platform that automates full care pathways—including assessment, triage, diagnosis, treatment, and discharge—via a smartphone app, delivering same-day video appointments to NHS patients while serving NHS Trusts and commissioners as primary customers.[1][2][5] The platform solves chronic NHS access issues by enabling autonomous AI care without human intervention, achieving >80% patient satisfaction equivalent to or better than face-to-face sessions and an average +6.16 improvement in MSK-HQ scores.[1][5] With CQC approval as the UK's only digital MSK provider and Class IIa medical device certification (first in Europe for fully autonomous AI diagnostics), Flok demonstrates proven clinical efficacy and scalability, starting with back pain and expanding to hip, knee, shoulder, and pelvic conditions.[1][2][5]
Flok Health was co-founded in 2022 by Finn Stevenson (CEO) and Ric, both with expertise in physiotherapy and AI, based in Cambridge, UK.[1][4] The idea emerged to address escalating NHS physiotherapy wait times and access barriers for MSK patients, evolving from initial tech development to securing regulatory approvals: CQC and MHRA in 2023, enabling first NHS trials in England and Scotland.[1][2] Pivotal moments include Class IIa certification in 2024 (or prior), allowing end-to-end autonomous care, and upcoming launches with multiple NHS Trusts, building on early trial success where patients reported high satisfaction and clinical outcomes.[1][2][5]
(Note: Search results reference a distinct "flok.org" entity focused on metabolic disorders data platforms [3], but this appears unrelated to Flok Health's physiotherapy focus, as confirmed by company site and news sources.[5])
Flok rides the AI-healthcare convergence trend, addressing global clinician shortages and rising MSK demands amid aging populations and post-pandemic backlogs in public systems like the NHS.[1][2][6] Timing is ideal: EU/UK regulatory progress enables AI autonomy (e.g., Class IIa breakthrough), while NHS embraces digital tools to slash waits—Flok pilots exemplify this shift.[2][4][6] Market forces favor it: escalating healthcare pressures demand scalable automation; Flok influences by setting benchmarks for AI clinics, paving expansion to other conditions and inspiring similar autonomous pathways worldwide.[1][2]
Flok is positioned to redefine community healthcare by scaling AI clinicians for high-volume needs, starting with MSK expansions (hip/knee/shoulder/pelvic) and new services in 2025.[1][2] Trends like AI regulatory acceleration and wearable/biometric integration will amplify growth, potentially exporting to global NHS-like systems facing capacity crises. Its influence may evolve from UK pioneer to worldwide standard-setter, automating routine care to unlock human expertise for complex cases—transforming "world-class care" from scarce to ubiquitous.[1][5]
Flok Health has raised $4.0M across 1 funding round. Most recently, it raised $4.0M Seed in November 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2025 | $4.0M Seed | Aidan Corbett |